|
CN111434665A
|
|
Ensultiamidinamide-aryl amide compound and application thereof in treating hepatitis B
|
|
CN111039942A
|
|
Nitrogen-containing heterocyclic compound, and preparation method, pharmaceutical composition and application thereof
|
|
CN110963958A
|
|
MDM2 inhibitor, and preparation method, pharmaceutical composition and application thereof
|
|
CN108341817A
|
|
Thiourea, carbamide compounds and application thereof
|
|
CN108341810A
|
|
Epithio carbamide compounds and application thereof
|
|
CN108264520A
|
|
Compound for treating hepatitis B and application thereof
|
|
CN108250122A
|
|
Sulfonamide-arylamides and its medicinal usage for treating hepatitis B
|
|
CN109678796A
|
|
PD-1/PD-L1 micromolecular inhibitor and its preparation method and application
|
|
CN109251212A
|
|
Inner ring sulfide amide-arylamides and its purposes for treating hepatitis B
|
|
CN109251158A
|
|
Sulphur amidine amides compound and its purposes for treating hepatitis B
|
|
CN108473525A
|
|
Deuterated HCV NS5b inhibitor nucleotide derivatives and application thereof
|
|
CN108250121A
|
|
Sulfonamide-arylamides and its medicinal usage for treating hepatitis B
|
|
CN108218807A
|
|
A kind of sulfone amidine as indoles amine -2,3- dioxygenase inhibitors and its preparation method and application
|
|
CN107266529A
|
|
One class suppresses the Large cyclic heterocyclic compound and its preparation and use of hepatitis C virus
|
